Abstract | OBJECTIVE: SAMPLE: Samples of grossly normal bladders (n = 4) and bladders from dogs with inflammatory bladder disease (13) or TCC (18), and cells of 5 established canine TCC cell lines. PROCEDURES: Expression of 5 miRNAs (miR-34a, let-7c, miR-16, miR-103b, and miR-106b) that target p53, Rb, or Bcl-2 protein pathways was determined for bladder samples and cells via quantitative real-time PCR assay. Effects of cisplatin (5μM) on proliferation and miRNA expression of cells were determined. RESULTS: Expression of miR-34a and miR-106b was significantly higher in TCC samples than it was in samples of grossly normal bladders. Expression of miR-34a, miR-16, miR-103b, and miR-106b was higher in TCC samples than it was in bladder samples from dogs with inflammatory bladder disease. Cells of established canine TCC cell lines that had the lowest growth after cisplatin treatment had increased miR-34a expression after such treatment. CONCLUSIONS AND CLINICAL RELEVANCE: Findings of this study indicated results of miRNA expression assays can be used to distinguish between samples of grossly normal bladders and bladders of dogs with inflammatory bladder disease or TCC. This finding may have clinical relevance because currently available diagnostic tests cannot be used to differentiate these tissues, and inflammatory bladder disease and TCC are both prevalent in dogs. Validation of miRNA expression assays as diagnostic tests may be warranted.
|
Authors | Ruth L Vinall, Michael S Kent, Ralph W deVere White |
Journal | American journal of veterinary research
(Am J Vet Res)
Vol. 73
Issue 10
Pg. 1626-33
(Oct 2012)
ISSN: 1943-5681 [Electronic] United States |
PMID | 23013190
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- MicroRNAs
- Cisplatin
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology)
- Carcinoma, Transitional Cell
(metabolism, veterinary)
- Cell Line
- Cell Proliferation
(drug effects)
- Cisplatin
(pharmacology)
- Cystitis
(metabolism, veterinary)
- Dog Diseases
(metabolism)
- Dogs
(metabolism)
- Female
- Gene Expression Regulation
(drug effects)
- Male
- MicroRNAs
(metabolism)
- Real-Time Polymerase Chain Reaction
(veterinary)
- Urinary Bladder
(metabolism)
- Urinary Bladder Diseases
(metabolism, veterinary)
- Urinary Bladder Neoplasms
(metabolism, veterinary)
|